lead news picture

Malaria vaccine approval first marred by efficacy question mark

29 July 2015  News and Analysis

Low protection rates in trials and uncertainty over cost-effectiveness leave vaccine's future up in the air


Biogen to develop gene therapies with AGTC

29 July 2015 Business

news image

$1bn deal gives Biogen rights to one clinical candidate and several earlier-stage programmes for rare eye diseases

Hikma boosts generics with Roxane buyout

29 July 2015 Business

news image

Acquiring the Boehringer Ingelheim subsidiary expands Hikma’s presence in US generics market

Celgene to buy immune-inflammatory specialist Receptos

29 July 2015 Business

news image

$7.2bn deal further strengthens Celgene’s position in immunology

Switzerland R&D spending falls after Horizon 2020 cash freeze  

Referendum vote to limit EU immigration has led to national research spending being cuts o...

Allergan steps away from generics with sale to Teva  

$40.5 billion deal gives Allergan cash to clear debt and fund further acquisitions, and ca...

Antifreeze polymer protects cells as they thaw  

Simple synthetic polymer found to enhance cryopreservation of red blood cells by inhibitin...

New Horizons sees red over Pluto’s atmosphere  

Reaction of methane breakdown products are responsible for the dwarf planet’s rosy hue

Battery buffer takes the strain  

Unconventional layered oxide that counteracts volume expansion in electrodes could help ba...

More News